Status | Study |
Recruiting |
Study Name: A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Date: 2017-03-27 Interventions: Other: High Water Intake After 6 months of usual, unchanged diet and fluid intake, participants will be |
Recruiting |
Study Name: Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease) Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2016-09-15 Interventions: Drug: Tolvaptan |
Recruiting |
Study Name: Feasibility Study of Metformin Therapy in ADPKD Condition: Polycystic Kidney, Autosomal Dominant Date: 2016-09-13 Interventions: Drug: Metformin Monitoring of |
Not yet recruiting |
Study Name: The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-04-08 Interventions: Device: Vessix Renal denervation using radio-ablation |
Recruiting |
Study Name: Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease Condition: Polycystic Kidney, Autosomal Dominant Date: 2015-12-23 Interventions: Drug: Metformin Monitoring of |
Enrolling by invitation |
Study Name: Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2014-09-25 Interventions: Drug: Tolvaptan (OPC-41061) Tolvaptan tablets (15 or 30 mg) will be self-administered orally as split-do |
Recruiting |
Study Name: Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2014-04-14 Interventions: Drug: Triptolide-Containing Formulation |
Withdrawn |
Study Name: Repository Study of Autosomal Dominant Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2013-11-07 |
Active, not recruiting |
Study Name: A Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condition: Polycystic Kidney, Autosomal Dominant Date: 2012-03-09 Interventions: Drug: KD019 (tesevatinib) Other Name: XL647 |
Completed |
Study Name: 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2011-10-11 Interventions: Drug: Tolvaptan MR 50/80 mg ca |